drugset
drugset / Trial / NCT03865394

Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells

NCT03865394 ↗

Phase 1/2 Completed 46 enrolled Medical University of Warsaw Polish Stem Cells Bank S.A. · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to investigate efficiency of applying of adipose-derived mesenchymal stem cells (ADSC) in treatment of chronic wounds in diabetic foot syndrome.

Timeline

Start
2019-07-01
Primary completion
2021-03-31
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject adipose-derived mesenchymal stem cells Cell therapy — Other

Indications

ulcer of lower limbs